Skip to content

ProtaGene vs RoslinCT

ProtaGene logo

ProtaGene

Analytic services for biologics and cell therapies

130 employees · est. 1997 · Heilbronn, Germany

VS
RoslinCT logo

RoslinCT

Your Advanced Cell & Gene Therapy CDMO Partner

350 employees · est. 2016 · Edinburgh, United Kingdom

ProtaGene is the older company (1997 vs 2016); RoslinCT is the larger of the two.

Side-by-Side Comparison

ProtaGene RoslinCT
Founded
1997 older 2016
Headquarters
Heilbronn, Germany Edinburgh, United Kingdom
Employees
130 350 larger
Industry
Biopharma, Biotechnology, Health and Wellness Biotechnology, Manufacturing
Funding Stage
Growth Private Equity
Total Funding
Not tracked yet $887.00K
Funding Rounds
1 2
Services
Advanced analytical solutions for biopharmaceuticals, Comprehensive evaluation of safety and efficacy, Integrated cell and gene therapy analytics, Custom molecule-specific assay development, GMP-compliant cell-based assays, State-of-the-art technology in analytics, Commercial-Stage Comparability Testing Not tracked yet
Target Customers
Biopharmaceutical companies, Cell and gene therapy developers, Researchers from discovery to market phases, Biologic product development teams, Regulatory affairs teams in biotechnology Not tracked yet
Taxonomy
CRO ServicesBiopharmaceutical AnalyticsGene Therapy AnalysisCell Therapy AnalysisProtein-Based TherapeuticsGene-Based Platforms +9 Advanced Cell TherapyGene TherapyCDMOContract Development And Manufacturing ServicesStem Cell ResearchCRISPR Technology +8
Website
protagene.com roslinct.com
ProtaGene logo

About ProtaGene

ProtaGene, founded in 1997 and headquartered in Germany, is a front-runner in providing analytic services for biologics and cell therapies. They offer comprehensive protein and gene analytic solutions to the biopharmaceutical and gene therapy industries. The company emerged from the merger of Prota...

RoslinCT logo

About RoslinCT

RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the groundbreaking technology cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has harnessed cutting-ed...

Also comparing in this category

Comparing more than these two?

Get ProtaGene, RoslinCT and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does ProtaGene compare?

A PDF of ProtaGene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

ProtaGene was founded in 1997, based in Heilbronn, Germany, with 130 employees. ProtaGene, founded in 1997 and headquartered in Germany, is a front-runner in providing analytic services for biologics and cell therapies. They offer comprehensive protein and gene analytic solutions. RoslinCT was founded in 2016, based in Edinburgh, United Kingdom, with 350 employees. RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the groundbreaking tech.
ProtaGene has raised no disclosed funding and RoslinCT $887.00K. Latest stage: ProtaGene Growth, RoslinCT Private Equity.
Both work in Biotechnology.

Compare ProtaGene with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ProtaGene on 14 May 2026, and RoslinCT on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout